These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 24695349

  • 21. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors.
    Shen J, Li W, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2009 Jul 30; 113(30):10436-44. PubMed ID: 19583238
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P.
    Biochem Pharmacol; 2006 May 14; 71(10):1459-69. PubMed ID: 16554039
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Phytoestrogenic Activity of Blackcurrant Anthocyanins Is Partially Mediated through Estrogen Receptor Beta.
    Nanashima N, Horie K, Maeda H.
    Molecules; 2017 Dec 29; 23(1):. PubMed ID: 29286333
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bisphenol AF as an Inducer of Estrogen Receptor β (ERβ): Evidence for Anti-estrogenic Effects at Higher Concentrations in Human Breast Cancer Cells.
    Okazaki H, Takeda S, Kakizoe K, Taniguchi A, Tokuyasu M, Himeno T, Ishii H, Kohro-Ikeda E, Haraguchi K, Watanabe K, Aramaki H.
    Biol Pharm Bull; 2017 Dec 29; 40(11):1909-1916. PubMed ID: 29093337
    [Abstract] [Full Text] [Related]

  • 27. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ, Sun J, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 1999 Jul 01; 42(13):2456-68. PubMed ID: 10395487
    [Abstract] [Full Text] [Related]

  • 28. Molecular Docking Reveals Binding Features of Estrogen Receptor Beta Selective Ligands.
    Książek P, Bryl K.
    Curr Comput Aided Drug Des; 2015 Jul 01; 11(2):137-51. PubMed ID: 26202886
    [Abstract] [Full Text] [Related]

  • 29. Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
    Bhavnani BR, Tam SP, Lu X.
    Endocrinology; 2008 Oct 01; 149(10):4857-70. PubMed ID: 18599548
    [Abstract] [Full Text] [Related]

  • 30. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J, Li W, Zhao Y, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2008 Mar 06; 112(9):2719-26. PubMed ID: 18266357
    [Abstract] [Full Text] [Related]

  • 31. Structure-Activity Relationship of para-Carborane Selective Estrogen Receptor β Agonists.
    Sedlák D, Wilson TA, Tjarks W, Radomska HS, Wang H, Kolla JN, Leśnikowski ZJ, Špičáková A, Ali T, Ishita K, Rakotondraibe LH, Vibhute S, Wang D, Anzenbacher P, Bennett C, Bartunek P, Coss CC.
    J Med Chem; 2021 Jul 08; 64(13):9330-9353. PubMed ID: 34181409
    [Abstract] [Full Text] [Related]

  • 32. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
    Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA.
    J Med Chem; 2001 Nov 22; 44(24):4230-51. PubMed ID: 11708925
    [Abstract] [Full Text] [Related]

  • 33. SAR Study on Estrogen Receptor α/β Activity of (Iso)flavonoids: Importance of Prenylation, C-Ring (Un)Saturation, and Hydroxyl Substituents.
    Mbachu OC, Howell C, Simmler C, Malca Garcia GR, Skowron KJ, Dong H, Ellis SG, Hitzman RT, Hajirahimkhan A, Chen SN, Nikolic D, Moore TW, Vollmer G, Pauli GF, Bolton JL, Dietz BM.
    J Agric Food Chem; 2020 Sep 30; 68(39):10651-10663. PubMed ID: 32945668
    [Abstract] [Full Text] [Related]

  • 34. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
    Minutolo F, Bellini R, Bertini S, Carboni I, Lapucci A, Pistolesi L, Prota G, Rapposelli S, Solati F, Tuccinardi T, Martinelli A, Stossi F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M.
    J Med Chem; 2008 Mar 13; 51(5):1344-51. PubMed ID: 18269232
    [Abstract] [Full Text] [Related]

  • 35. Interaction of Coumarin Phytoestrogens with ERα and ERβ: A Molecular Dynamics Simulation Study.
    Wang T, Wang Y, Zhuang X, Luan F, Zhao C, Cordeiro MNDS.
    Molecules; 2020 Mar 05; 25(5):. PubMed ID: 32150902
    [Abstract] [Full Text] [Related]

  • 36. Estrogenic properties of naturally occurring prenylated isoflavones in U2OS human osteosarcoma cells: Structure-activity relationships.
    Djiogue S, Njamen D, Halabalaki M, Kretzschmar G, Beyer A, Mbanya JC, Skaltsounis AL, Vollmer G.
    J Steroid Biochem Mol Biol; 2010 Jun 05; 120(4-5):184-91. PubMed ID: 20420908
    [Abstract] [Full Text] [Related]

  • 37. A high-affinity subtype-selective fluorescent probe for estrogen receptor β imaging in living cells.
    Hu Z, Yang L, Ning W, Tang C, Meng Q, Zheng J, Dong C, Zhou HB.
    Chem Commun (Camb); 2018 Apr 12; 54(31):3887-3890. PubMed ID: 29610818
    [Abstract] [Full Text] [Related]

  • 38. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 12; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 39. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes.
    Tuccinardi T, Bertini S, Martinelli A, Minutolo F, Ortore G, Placanica G, Prota G, Rapposelli S, Carlson KE, Katzenellenbogen JA, Macchia M.
    J Med Chem; 2006 Aug 10; 49(16):5001-12. PubMed ID: 16884312
    [Abstract] [Full Text] [Related]

  • 40. Selectively targeting estrogen receptors for cancer treatment.
    Shanle EK, Xu W.
    Adv Drug Deliv Rev; 2010 Oct 30; 62(13):1265-76. PubMed ID: 20708050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.